Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Quipt Home Medical Corp (QIPT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/10/2025: QIPT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $3.4
1 Year Target Price $3.4
| 3 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -58.11% | Avg. Invested days 19 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/10/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 83.08M USD | Price to earnings Ratio - | 1Y Target Price 3.4 |
Price to earnings Ratio - | 1Y Target Price 3.4 | ||
Volume (30-day avg) 5 | Beta 0.17 | 52 Weeks Range 1.35 - 4.07 | Updated Date 07/11/2025 |
52 Weeks Range 1.35 - 4.07 | Updated Date 07/11/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.21 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -3.6% | Operating Margin (TTM) -1.67% |
Management Effectiveness
Return on Assets (TTM) -0.32% | Return on Equity (TTM) -8.1% |
Valuation
Trailing PE - | Forward PE 56.82 | Enterprise Value 162487920 | Price to Sales(TTM) 0.34 |
Enterprise Value 162487920 | Price to Sales(TTM) 0.34 | ||
Enterprise Value to Revenue 0.67 | Enterprise Value to EBITDA 3.3 | Shares Outstanding 43444000 | Shares Floating 34533179 |
Shares Outstanding 43444000 | Shares Floating 34533179 | ||
Percent Insiders 15.27 | Percent Institutions 56.09 |
Upturn AI SWOT
Quipt Home Medical Corp
Company Overview
History and Background
Quipt Home Medical Corp. was founded in 2015 and has grown through acquisitions and organic growth to become a provider of durable medical equipment (DME) and respiratory care solutions.
Core Business Areas
- Durable Medical Equipment (DME): Supplies a wide range of DME, including mobility aids, hospital beds, and other medical equipment for home use.
- Respiratory Care: Provides respiratory equipment and supplies, including oxygen concentrators, ventilators, and CPAP/BiPAP machines.
- Home Medical Supplies: Offers a variety of medical supplies used in the home, such as wound care products, incontinence supplies, and personal hygiene items.
Leadership and Structure
The leadership team includes Greg Crawford (Chairman & CEO), Hardik Mehta (CFO). The organizational structure is hierarchical, with various departments responsible for different aspects of the business.
Top Products and Market Share
Key Offerings
- Oxygen Concentrators: Provides oxygen concentrators for patients with respiratory conditions. Competitors: Inogen (INGN), ResMed (RMD). Revenue contribution is significant, part of respiratory segment which contributes around 45% to overall revenue.
- CPAP/BiPAP Machines: Offers CPAP/BiPAP machines for sleep apnea treatment. Market Share for CPAP/BiPAP market is fragmented with ResMed (RMD), Philips Respironics being major competitors. Revenue contribution significant, part of respiratory segment which contributes around 45% to overall revenue.
- Mobility Equipment: Provides mobility equipment like wheelchairs and walkers. Competitors: Permobil, Pride Mobility Products. The DME segment contributes about 55% of total revenue.
Market Dynamics
Industry Overview
The DME and respiratory care market is growing due to the aging population, increasing prevalence of chronic diseases, and a shift towards home-based healthcare. Market is highly fragmented with national and regional players.
Positioning
Quipt Home Medical Corp. is positioned as a consolidator in the fragmented DME market, focusing on acquisitions and organic growth to expand its market share. They have a competitive advantage in excellent customer service.
Total Addressable Market (TAM)
The US home medical equipment market is estimated to be $60 billion. Quipt is positioned to capture more of the market through acquisitions and expansion of its services.
Upturn SWOT Analysis
Strengths
- Strong acquisition strategy
- Recurring revenue model
- Geographic diversification
- Strong cash flow generation
- Excellent customer service
Weaknesses
- High debt levels due to acquisitions
- Integration risks with acquisitions
- Dependence on reimbursement rates
- Susceptibility to competitive pressures
- Reliance on key personnel
Opportunities
- Further acquisitions in a fragmented market
- Expansion of product and service offerings
- Growth in telehealth and remote patient monitoring
- Increased demand for home-based healthcare
- Growing aging population.
Threats
- Changes in government reimbursement policies
- Increased competition from larger players
- Rising interest rates
- Economic downturn
- Supply chain disruptions.
Competitors and Market Share
Key Competitors
- RMD
- INGN
- HME
Competitive Landscape
Quipt Home Medical Corp. competes with larger, more established players in the DME and respiratory care market. The company differentiates itself through its customer service and acquisition strategy.
Major Acquisitions
NorCal Respiratory Services, Inc.
- Year: 2023
- Acquisition Price (USD millions): 10.7
- Strategic Rationale: Enhances the Companyu2019s respiratory care presence in the Northern California region.
Lake Medical Equipment
- Year: 2024
- Acquisition Price (USD millions): 5.5
- Strategic Rationale: Expands Quipt's footprint and strengthens its respiratory care capabilities, and establishes a strong presence in a key geographic area.
Growth Trajectory and Initiatives
Historical Growth: Quipt Home Medical Corp. has experienced rapid growth through acquisitions and organic expansion. Revenue has increased significantly over the past few years.
Future Projections: Analysts project continued growth in revenue and earnings, driven by further acquisitions and expansion of existing operations.
Recent Initiatives: Recent initiatives include the acquisition of new DME providers, expansion of respiratory care services, and investment in technology to improve operational efficiency.
Summary
Quipt Home Medical Corp. is a rapidly growing DME and respiratory care provider with a strong acquisition strategy and a recurring revenue model. The company faces challenges related to high debt levels and reimbursement pressures, but it is well-positioned to capitalize on the growing demand for home-based healthcare. Quipt needs to continue improving operational efficiency while focusing on integrating acquired companies effectively. Managing government reimbursement risks is also essential for sustained growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Quipt Home Medical Corp
Exchange NASDAQ | Headquaters Wilder, KY, United States | ||
IPO Launch date 2021-05-27 | Chairman, President & CEO Mr. Gregory J. Crawford | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 1200 | Website https://quipthomemedical.com |
Full time employees 1200 | Website https://quipthomemedical.com | ||
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and home medical equipment, such as stair lifts, ramps, bath safety equipment, daily living, and ambulatory, as well as home modification solutions. It also engages in the rental and sale of medical equipment and related devices. In addition, the company offers solutions that supports patients dealing with heart and pulmonary disease, sleep apnea, reduced mobility, COPD, neuromuscular disorders, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.